Eli Lilly 2003 Annual Report Download - page 3
Download and view the complete annual report
Please find page 3 of the 2003 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2 -
3 -
4 -
5 -
6 -
7 -
8 -
9 -
10 -
11 -
12 -
13 -
14 -
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
 |
 |
1
2003 FINANCIAL HIGHLIGHTS
Eli Lilly and Company and Subsidiaries
(Dollars in millions, except per-share data) Year Ended December 31 2003 2002 Change %
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $12,582.5 $11,077.5 14
Research and development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,350.2 2,149.3 9
Research and development as a percent of sales . . . . . . . . . . . . . . . . 18.7% 19.4%
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2,560.8 $ 2,707.9 (5)
Earnings per share—basic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.38 2.51 (5)
Earnings per share—diluted. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.37 2.50 (5)
Dividends paid per share. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.34 1.24 8
Capital expenditures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,706.6 1,130.9 51